Corporate News

October 11, 2018 – Phoenix, AZ, USA

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, excitedly announces its newest launch, SPLENDOR X— the first solid state laser system equipped with the unique BLEND X technology for fast and effective hair removal and skin solutions. The technology will be showcased for the first time at the 2018 American Society of Dermatological Surgery – ASDS in Phoenix from October 11th-October 14th, 2018.
Read More

July 2, 2018 – Las Vegas, NV, USA

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, is excited to announce its newest launch, NuEra tight– a non-invasive, intelligent temperature-controlled technology for both superficial and deep heating that treats a variety of conditions such as skin laxity and the appearance of cellulite.
Read More

CO2 laser excision of endometrial cells reduces pain and recurrence while preserving fertility

March 26, 2018 – Yokne'am, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, today announced the publication of meaningful new clinical evidence for its surgical intervention for patients with endometriosis. Lumenis is excited to share this message of hope and innovation for women with this historically misunderstood disease as part of the company’s annual support of Endometriosis Awareness Month.
Read More

March 19, 2018 – Yokne'am, Israel

Lumeni Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, announced that it will again be supporting the International Scar Treatment Conference in Israel, which will be held for the second time in Tel Aviv, on March 21st-22nd, 2018.
Read More

Reduction in Lithotripsy procedure time and benefits in BPH treatments

March 16, 2018 – Yokne'am, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announces the release of significant new clinical evidence in lithotripsy as well as initial clinical benefits in benign prostatic hyperplasia (BPH) treatments using the MOSES™ Technology at the 33rd annual European Association of Urology Congress (EAU18), taking place in Copenhagen, March 16-19, 2018.
Read More
Keep Me Updated